Novel VEGFR2 inhibitors with thiazoloquinoxaline scaffold targeting hepatocellular carcinoma with lower cardiotoxic impact

por El-Hazek, Reham M. M., Zaher, Nashwa H., El-Gazzar, Mostafa G. M., Fadel, Noha A., El-Sabbagh, Walaa A.
Publicado 2023